Skip to content

Veracyte, Inc. Sustainability Reports

Veracyte, Inc. is a global diagnostics company that develops and commercializes advanced genomic tests to improve cancer screening, diagnosis, and treatment decisions.

Sector: Healthcare & social services

Country: United States

Exchange: Nasdaq

ISIN: US92337F1075

11 reports from 2014 to 2025